Early Diagnosis and Prevention of Sporadic Colorectal Cancer

R. Lambert; D. Provenzale; N. Ectors; H. Vainio; M. F. Dixon; W. Atkin; M. Werner; S. Franceschi; H. Watanabe; G. N. Tytgat; A. T. Axon; H. Neuhaus

doi:10.1055/s-2001-18938

Endoscopy 2001; 33(12): 1042-1064
DOI: 10.1055/s-2001-18938

Review

Early Diagnosis and Prevention of Sporadic Colorectal Cancer[1]

R. Lambert ¹ , D. Provenzale ² , N. Ectors ³ , H. Vainio ¹ , M. F. Dixon ⁴ , W. Atkin ⁵ , M. Werner ⁶ , S. Franceschi ¹ , H. Watanabe ⁷ , G. N. Tytgat ⁸ , A. T. Axon ⁹ , H. Neuhaus ¹⁰

¹ International Agency for Research on Cancer, Lyon, France
² Institute for Clinical and Epidemiological Research, Durham, North Carolina, USA
³ Department of Pathology, Leuven, Belgium
⁴ Academic Unit of Pathology Leeds, UK
⁵ Colorectal Cancer Unit, St Mark's Hospital, Harrow, UK
⁶ Institute of Pathology, Munich, Germany
⁷ Division of Molecular and Diagnostic Pathology, Niigata, Japan
⁸ Academisch Medisch Centrum, Amsterdam, The Netherlands
⁹ Leeds General Infirmary, Leeds, UK
¹⁰ Evangelisches Krankenhaus, Düsseldorf, Germany

Abstract

Full Text

References

1 Bond J H. Clinical evidence for the adenoma-carcinoma sequence, and the management of patients with colorectal adenomas. Semin Gastrointest Dis. 2000; 11 176-184
2 Kudo S. Early colorectal cancer. Detection of depressed types of colorectal carcinoma. Tokyo; Igaku-Shoin, Medical Publishers 1996
3 Mitooka H. Flat neoplasms in the adenocarcinoma sequence in Japan. Semin Gastrointest Dis. 2000; 11 238-247
4 Rembacken B, Fujii T, Cairns A, et al. Flat and depressed colonic neoplasms: a prospective study of 1000 colonoscopies in the UK. Lancet. 2000; 355 1211-1214
5 Kudo S, Kashida H, Tamura T. Early colorectal cancer: flat or depressed type. J Gastroenterol Hepatol. 2000; 15 D66-D70
6 Tamegai Y, Kudo S, Kusaka H, et al. Developmental process of depressed type colorectal cancers (abstract). Gut. 2000; 32 (Suppl. 1) E263
7 Umetani N, Sasaki S, Masaki T, et al. Involvement of APC and K-ras mutation in nonpolypoid colorectal tumorigenesis. Br J Cancer. 2000; 82 9-15
8 Van Wyk R, Slezak P, Hayes V M, et al. Somatic mutations of the APC, KRAS and TP53 genes in nonpolypoid colorectal adenomas. Genes Chromosomes Cancer. 2000; 27 202-208
9 Ajiko Y, Watanabe H, Kazama S, Hashidate H, et al. Early colorectal cancer with special reference to the superficial nonpolypoid type from a histopathologic point of view. World J Surg. 2000; 24 1075-1080
10 Ajioka Y, Watanabe H, Jass J R, et al. Infrequent K-ras codon 12 mutation in serrated adenomas of human colorectum. Gut. 1998; 42 680-684
11 Schlemper R J, Riddell R H, Kato Y, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut. 2000; 47 251-255
12 Rugge M, Correa P, Dixon M F, et al. Gastric dysplasia the Padova international classification. Am J Surg Pathol. 2000; 24 167-176
13 Kobayashi M, Watanabe H, Maeo S, et al. Correlation of histological atypia and cancer sprouting with vascular permeation and lymph nodal metastasis according to our new histological classification of submucosal invasion of colorectal carcinomas (in Japanese). Stomach Intestine. 1994; 29 1151-1160
14 Longacre T A, Fenoglio-Preiser C M. Mixed hyperplastic adenomatous polyps/serrated adenomas. Am J Surg Pathol. 1990; 14 524-537
15 Jaramillo E, Watanabe M, Rubio C, et al. Small colorectal serrated adenomas: endoscopic findings. Endoscopy. 1997; 29 1-3
16 Biermer-Huttmann A E, Walsh M F, McGuckin M A, et al. Immunohistochemical staining patterns of MUC1, MUC2, MUC4, and MUC5AC mucins in hyperplastic polyps, serrated adenomas, and traditional adenomas of the colorectum. J Histochem Cytochem. 1999; 47 1039-1048
17 Hiyama T, Yokozaki H, Shimamoto F, et al. Frequent p53 gene mutations in serrated adenomas of the colorectum. J Pathol. 1998; 186 131-139
18 Petersen S, Thames H D, Nieder C, et al. The results of colorectal cancer treatment by p53 status: treatment-specific overview. Dis Colon Rectum. 2001; 44 322-333
19 Vaesen H S, Watson P, Mecklin J P, et al. New clinical criteria for hereditary non-polyposis colorectal cancer (HNPCC-Lynch syndrome). Proposed by the International Collaborative Group of HPNCC. Gastroenterology. 1999; 116 1453-146
20 Gryfe R, Kim H, Hsieh E TK, Aronson M D, et al. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med. 2000; 342 69-77
21 Cawkwell L, Gray S, Murgatroyd H, et al. Choice of managememt strategy for colorectal cancer based on a diagnostic immumohistochemical test for defective mismatch repair. Gut. 1999; 45 409-415
22 Spaepen M, Vankeirsbilck B, Tejpar S, et al. Germline mutations of the mismatch repair genes in Belgian hereditary nonpolyposis colon cancer patients (Submitted). Hum Mutat.
23 Roncucci L, Pedroni M, Vaccina F, et al. Aberrant crypt foci in colorectal carcinogenesis: Cell and crypt dynamics. Cell Prolif. 2000; 33 1-18
24 Jass J R. Serrated route to colorectal cancer: back street or super highway. J Pathol. 2001; 193 283-285
25 Lynch H T, Smyrk T, McGinn T, et al. Attenuated familial adenomatous polyposis (AFAP). A phenotypically and genotypically distinctive variant of FAP. Cancer. 1995; 76 2427-2433
26 Rex D K. Endoscopic screening for colorectal cancer: recent studies from Indiana university. Indiana Med. 1984; 87 68-73
27 Makinen M J, George S M, Jernvall P, et al. Colorectal carcinoma associated with serrated adenoma - prevalence, histological features and prognosis. J Pathol. 2001; 193 286-294
28 Cairns A, Dixon M F, Martin I G, et al. Flat adenomas. A distinct biological entity and a new definition. Gut. 1999; 44 (Suppl. 1) A142
29 Kudo S. Endoscopic mucosal resection of flat and depressed types of early colorectal cancer. Endoscopy. 1993; 31 455-461
30 Kudo S, Kashida H, Nakajima T, et al. Endoscopic diagnosis and treatment of early colorectal cancer. World J Surg. 1997; 21 694-701
31 Gilat T, Fireman Z, Grossman A, et al. Colorectal cancer in patients with ulcerative colitis. A population study in central Israel. Gastroenterology. 1988; 94 870-877
32 Gyde S N, Prior P, Allan R N, et al. Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centers. Gut. 1988; 29 206-217
33 Friedman S, Rubin P H, Bodian C, et al. Present DH screening and surveillance colonoscopy in chronic Crohn's colitis. Gastroenterology. 2001; 120 820-826
34 Gillen C D, Andrews H A, Prior P, et al. Crohn's disease and colorectal cancer. Gut. 1994; 35 651-655
35 Gillen C D, Walmsley R S, Prior P. Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis. Gut. 1994; 35 1507-1508
36 Bernstein CN,Shanahan F, Weinstein W M. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis?. Lancet. 1994; 343 71-74
37 Manning A P, Bulgim O R, Dixon M F, et al. Screening by colonoscopy for colonic epithelial dysplasia in inflammatory bowel disease. Gut. 1987; 28 1489-1494
38 Connell WR Lennard Jones C E, Williams C B, et al. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology. 1994; 107 934-944
39 Gorfine S R, Bauer J J, Harris M T, et al. Dysplasia complicating chronic ulcerative colitis: is immediate colectomy warranted?. Dis Colon Rectum. 2000; 43 1575-1581
40 Sigel J E, Petras R E, Lashner B A, et al. Intestinal adenocarcinoma in Crohn's disease: a report of 30 cases with a focus on coexisting dysplasia. Am J Surg Pathol. 1999; 23 651-655
41 Schneider A, Stolte M. Clinical and pathomorphological findings in patients with colorectal carcinoma complicating ulcerative colitis. Z Gastroenterol. 1993; 31 192-197
42 Odze R D. Adenomas and adenoma-like DALMs in chronic ulcerative colitis: a clinical, pathological, and molecular review. Am J Gastroenterol. 1999; 94 1746-1750
43 Tytgat G N, Dhir V, Gopinath N. Endoscopic appearance of dysplasia and cancer in inflammatory bowel disease. Eur J Cancer. 1995; 31 1174
44 Jaramillo E, Watanabe M, Befrits R, et al. Small, flat colorectal neoplasias in long-standing ulcerative colitis detected by high-resolution electronic video endoscopy. Gastrointest Endosc. 1996; 44 95-96
45 Wong N A, Mayer N J, MacKell S, et al. Immunohistochemical assessment of Ki67 and p53 expression assists the diagnosis and grading of ulcerative colitis-related dysplasia. Histopathology. 2000; 37 108-114
46 Kudo S, Hirota S, Nakajima T, et al. Colorectal tumours and pit pattern. J Clin Pathol. 1994; 47 880-885
47 Kudo S, Rubio C A, Teixeira C R, et al. Pit pattern in colorectal neoplasia: endoscopic magnifying view. Endoscopy. 2001; 33 367-373
48 Kato S, Fujii T, Koba I, Sano Y, et al. Assessment of colorectal lesions using magnifying colonoscopy and mucosal dye spraying: can significant lesions be distinguished?. Endoscopy. 2001; 33 306-310
49 Kawano H, Tsura O, Ikeda H, et al. Diagnosis of the level of depth in superficial depressed type colorectal tumors in terms of stereomicroscopic pit patterns. Internat J Oncol. 1998; 12 769-775
50 O’Brien M J, Winawer S J, Zauber A G, et al. Blinded assessment of the flat adenoma in the National Polyp Study does not demonstrate an excess risk for high grade dysplasia initially or for advanced adenomas at surveillance. Gastroenterology. 2001; 120 (5 Suppl. 1) A96
51 Bauerfeind P. Colon tumors and colonoscopy. Endoscopy. 2001; 33 949
52 Masaki T, Sheffield J P, Talbot I C, et al. Nonpolypoid adenoma of the large intestine. Int J Colorectal Dis. 1994; 9 180-183
53 Fernandez E, Bosetti C, La Vecchia C, et al. Sex differences in colorectal cancer mortality in Europe, 1955 - 1996. Eur J Cancer Prev. 2000; 9 99-104
54 McMichael A J, Giles G G. Colorectal cancer. In: Sidebottom E, (eds). Trends in cancer incidence and mortality. Cancer Surv 1994 19/20: 77-98
55 Wingo P A, Ries L AG, Giovino G A, et al. Annual report to the nation of the status of cancer, 1973 - 1996, with a special section on lung cancer and tobacco smoking. J Natl Cancer Inst. 1999; 91 675-690
56 World Cancer Research Fund .Food, nutrition and the prevention of cancer: a global perspective. Washington, DC; American Institute for Cancer Research, 1997
57 Giovannuci E, Rimm E B, Stempfer M J, et al. A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in US men. J Natl Cancer Inst. 1994; 86 183-191
58 Giovannuci E,Colditz G A, Stempfer M J, et al. A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in US women. J Natl Cancer Inst. 1994; 86 192-199
59 Slattery M L, Edwards S L, Ma K N, et al. Physical activity and colon cancer: a public health perspective. Ann Epidemiol,. 1997; 7 137-145
60 La Vecchia C, Braga C, Franceschi S, et al. Population-attributable risk for colon cancer in Italy. Nutr Cancer. 1999; 33 196-200
61 International Agency for Research on Cancer .IARC Handbook of cancer prevention, vol 6. Weight control and physical activity. Lyon; IARC Press, 2001 In press
62 Bergstrom A, Pisani P, Tenet V, et al. Overweight as an avoidable cause of cancer in Europe. Int J Cancer. 2001; 91 421-430
63 Bruce R W, Giacca A, Medline A. Possible mechanisms relating diet and risk of colon cancer. Cancer Epidemiol Biol Prev. 2000; 9 1271-1279
64 Michels K B, Giovannucci E, Joshipura K J, et al. Prospective study of fruit and vegetable consumption and incidence of colon and rectal cancers. J Natl Cancer Inst. 2000; 92 1740-1752
65 Schottenfeld D, Winamar S J. Cancers of the large intestine. In: Schottenfeld D, Fraumeni JF (eds). Cancer epidemiology and prevention. New York; Oxford University Press, 1996 2nd ed: 813-840
66 Wilson J MG, Yunger G. The principles and practice of screening for disease. Geneva; WHO, 1968
67 Calman K. Developing screening in the NHS. J Med Screen. 1994; 2 101-104
68 Levin B, Bond J. Colorectal cancer screening. Recommendations of the US Preventive Services Task Force. Gastroenterology. 1996; 111 1381-1384
69 Rex D K, Johnson A, Lieberman A, et al. Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology. Am J Gastroenterol. 2000; 95 868-877
70 Farrands P A, Hardcastle J D, Chamberlain J, et al. Factors affecting compliance with screening for colorectal cancer. Community Med. 1984; 6 (1) 12-19
71 Sutton S, Wardle W, Taylor T, et al. Predictors of attendance in the UK flexible sigmoidoscopy screening trial. J Med Screen. 2000; 7 99-104
72 Neilson A, Whynes D. Determinants of persistent compliance with screening for colorectal cancer. Soc Sci Med. 1995; 41 365-374
73 Wardle J, Sutton S, Williamson S, et al. Psychosocial influences on older adults’ interest in participating in bowel cancer screening. Prev Med. 2000; 31 323-334
74 Mandel J, Bond J, Church T, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med. 1993; 328 1365-1371
75 Mandel J, Church T, Ederer F, et al. Colorectal cancer mortality: Effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst. 1999; 91 434-437
76 Hardcastle J, Chamberlain J, Robinson M, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996; 348 1472-1477
77 Kronborg O, Fenger C, Olsen J, et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996; 348 1467-1471
78 Rex D, Cutler C, Lemmel G, et al. Colonoscopic miss rates and adenomas determined by back-to-back colonoscopies. Gastroenterology. 1997; 112 24-28
79 Mandel J, Church T, Bond J, et al. The effect of fecal occult blood screening on the incidence of colorectal cancer. N Engl J Med. 2000; 343 1603-1607
80 Hart A, Kudo S, Mackay E, et al. Flat adenomas exist in asymptomatic people - important implications for colorectal-cancer screening programs. Gut. 1998; 43 229-231
81 Robinson M, Hardcastle J, Moss S, et al. The risks of screening: data from the Nottingham randomised controlled trial of faecal occult blood screening for colorectal cancer. Gut. 1999; 45 588-592
82 Atkin W. Screening for colorectal cancer: the heart of the matter. Gut. 1999; 45 480-481
83 Thiis-Evensen E, Hoff G, Sauar J, et al. Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scand J Gastroenterol. 1999; 34 414-420
84 Waye J, Kahn O, Auerbach M. Complications of colonoscopy and flexible sigmoidoscopy. Gastrointest Endosc Clin N Am. 1996; 6 343-377
85 Anderson M, Pasha T, Leighton J. Endoscopic perforation of the colon: lessons from a 10-year study. Am J Gastroenterol. 2000; 95 3418-3422
86 Towler B, Irwig L, Glasziou P, et al. Systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, Hemoccult. BMJ. 1998; 317 559-565
87 Selby J V, Friedman G D, Quesenberry C J, et al. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. Engl J Med. 1992; 326 653-657
88 Atkin W, Edwards R, Wardle J, et al. Investigators MF-ST. UK randomised trial of “once only” flexible sigmoidoscopy screening: baseline results. Endoscopy. 1999; 31 (Suppl. 1) E1
89 Senore C, Segnan N, Rossini F, et al. Screening for colorectal cancer by once-only sigmoidoscopy: a feasibility study in Turin, Italy. J Med Screen. 1996; 3 72-78
90 Winawer S J, Zauber A G, O'Brien M J, et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med. 1993; 329 1977-1981
91 Muller A, Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy. Ann Intern Med. 1995; 123 904-910
92 Kavanagh A, Giovannucci E, Fuchs C, et al. Screening endoscopy and risk of colorectal cancer in United States men. Cancer Causes Control. 1998; 9 455-462
93 Gilbertsen V A, Nelms J M. The prevention of invasive cancer of the rectum. Cancer. 1978; 41 1137-1139
94 Atkin W S, Morson B C, Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas (see comments). N Engl J Med. 1992; 326 658-662
95 Newcomb P A, Norfleet R G, Storer B E, et al. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer lnst. 1992; 84 1572-1575
96 Friedman G D, Collen M F, Fireman B H. Multiphasic Health Checkup Evaluation: a 16-year follow-up. J Chron Dis. 1986; 39 453-463
97 Wagner J L, Tunis S, Brown M, et al. Cost-effectiveness of colorectal cancer screening in average-risk adults. In: Young GP, Rozen P, Levin B (eds). Prevention and early detection of colon cancer. London; WB Saunders, 1996: 321-356
98 Torrance G W, Thomas W H, Sackett D L. A utility maximization model for evaluation of health care programs. Health Serv Res. 1972; 7 118-133
99 Rich J S, Black W C. When should we stop screening?. Eff Clin Pract. 2000; 3 78-84
100 Loeve F, Brown M L, Boer R, et al. Endoscopic colorectal cancer screening: a cost-saving analysis. J Natl Cancer Inst. 2000; 92 557-563
101 Khandker R K, Dulski J D, Kilpatrick J B, et al. A decision model and cost-effectiveness analysis of colorectal cancer screening and surveillance guidelines for average-risk adults. Intl J Technol Assess Health Care. 2000; 16 799-810
102 Frazier A L, Golditz G A, Fuchs C S, et al. Cost-effectiveness of screening for colorectal cancer in the general population. JAMA. 2000; 284 1954-1961
103 Sonnenberg A, Delcó F, Inadomi J M. Cost-effectiveness of colonoscopy in screening for colorectal cancer. Ann Intern Med. 2000; 133 573-584
104 Provenzale D, Homan R K, Oddone E Z. Screening colonoscopy in average risk individuals is cost-effective compared with other practices (abstract). Am J Gastroenterol. 1999; 94 424
105 Gold M R, Siegel J E, Russell L B. Cost-effectiveness in health and medicine. New York; Oxford University Press, 1996
106 Winawer S J, Fletcher R H, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology. 1997; 112 594-642
107 van der Maas P J, de Konig J G, van Ineveld B M, et al. The cost-effectiveness of breast cancer screening. Int J Cancer. 1989; 43 1055-1060
108 Sonnenberg A, Delcó F, Bauerfeind P. Is virtual colonoscopy a cost-effective option to screen for colorectal cancer?. Am J Gastroenterol. 1999; 94 2268-2274
109 Burn J, Chapman P D, Bishop D T, et al. Susceptibility markers in colorectal cancer. In: Miller AB, Bartsch H, Boffetta P, et al. (eds). Biomarkers in Cancer Chemoprevention. Lyon; IARC Press, 2001: 131-137
110 Potter J D. Colorectal cancer: molecules and populations. J Natl Cancer Inst. 1999; 91 916-932
111 Bruce W R, Giacca A, Medline A. Possible mechanisms relating to diet and risk of colon cancer. Cancer Epidemiol Biomarkers Prev. 2000; 9 1271-1279
112 Corpet D E, Parnaud G. Polyethylene-glycol, a potent suppressor of azoxymethane-induced colonic aberrant crypt foci in rats. Carcinogenesis. 1999; 20 915-918
113 Naigamwalla D, Chia M C, Tran T T, et al. Polyethylene glycol 8000 and colon carcinogenesis: inhibition in the F344 rat, promotion in the Min mouse. Cancer Res. 2000; 60 6856-6858
114 Alberts D S, Martinez M E, Roe D J, et al. Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians’ Network. N Engl J Med. 2000; 342 1156-1162
115 Schatzkin A, Lanza E, Corle D, et al. Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group. N Engl J Med. 2000; 342 1149-1155
116 Eaden J, Abrams K, Ekbom A, et al. Colorectal cancer prevention in ulcerative colitis: a case-control study. Aliment Pharmacol Ther. 2000; 14 145-153
117 Chinery R, Coffey R J, Graves-Deal R, et al. Prostaglandin J2 and 15-deoxy-delta-12,14-prostaglandin J2 induce proliferation of cyclooxygenase-depleted colorectal cancer cells. Cancer Res. 1999; 59 2739-2746
118 Erickson B A, Longo W E, Panesar N, et al. The effect of selective cyclooxygenase inhibitors on intestinal epithelial cell mitogenesis. J Surg Res. 1999; 81 101-107
119 International Agency for Research on Cancer .IARC handbooks of cancer prevention, vol 1. Non-steroidal anti-inflammatory drugs. Lyon; IARC Press, 1997: 1-202
120 Vainio H, Bianchini F. Prevention of disease with pharmaceuticals. Pharmacol Toxicol. 2001; 88 111-118
121 International Agency for Research on Cancer .IARC handbooks of cancer prevention, vol 2. Carotenoids. Lyon; IARC Press, 1998: 1-326
122 Marshall J R. Beta-carotene: a miss for epidemiology. J Natl Cancer Inst. 1999; 91 2068-2069
123 Bussey H J, DeCosse J J, Deschner E E, et al. A randomized trial of ascorbic acid in polyposis coli. Cancer. 1982; 50 1434-1439
124 Malila N, Virtamo J, Virtanen M, et al. The effect of alpha-tocopherol and beta-carotene supplementation on colorectal adenomas in middle-aged male smokers. Cancer Epidemiol Biomarkers Prev. 1999; 8 489-493
125 Albanes D, Malila N, Taylor P R, et al. Effects of supplemental alpha-tocopherol and beta-carotene on colorectal cancer: results from a controlled trial (Finland). Cancer Causes Control. 2000; 11 197-205
126 DeFronzo R A, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991; 14 173-194
127 Sturmer T, Glynn R J, Lee I M, et al. Aspirin use and colorectal cancer: post-trial follow-up data from the Physicians’ Health Study. Ann Intern Med. 1998; 128 713-720
128 Steinbach G, Lynch P M, Phillips R K, et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med. 2000; 342 1946-1952

1 Text prepared at the Third European Endoscopy Forum, which was supported by an educational grant from Olympus, in Faro, Portugal, June 8 - 10, 2001.

R. Lambert, M.D.

Descriptive Epidemiology Unit
International Agency for Research on Cancer

150 cours Albert Thomas
Lyon 69372 cedex 08
France

Fax: + 33-4-72738650

Email: lambert@iarc.fr